Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study.
about
Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylationPhosphorylated p70S6K in noninvasive low-grade urothelial carcinoma of the bladder: correlation with tumor recurrence.P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro.AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway.mTOR inhibitors in urinary bladder cancer.The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability.Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients.Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.Meta-analysis of the prognostic value of p-4EBP1 in human malignancies.A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
P2860
Q28567470-7150A211-4226-492E-9328-8335E43F3BFEQ33922437-6C4ED957-0B48-44C0-8ECB-ACA76AF7699BQ35089340-B2DE390C-E04A-483B-A4C5-C6301E33E2F5Q35125879-FE6B645A-38E9-4CE8-BF38-685AAF3CD2ACQ36027204-C6DD9B7A-7370-472C-937F-2F45E39C1E9FQ37482647-370EB040-F46C-46AE-B933-70371CB394D9Q37622192-93A7207C-044B-456B-87D0-D5F219070C1EQ38737064-5E7F49D5-4BF7-4DF5-A43E-403E520A364AQ38930235-A4553CBD-D44E-422B-A81D-926F675F22D3Q41913207-A6A3D39C-86C2-47E7-B2DB-05FF23656319Q42378347-CB03315C-2152-4D42-8E98-893C59E664B4Q47100939-77B434AF-038B-43A8-9FF3-C8EA88CD9CD4Q49515435-CD2EA85D-A85F-49F4-B233-46B93138F1C6Q54285690-9BBE2BFD-2682-4B00-B653-6128E05A213D
P2860
Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@ast
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@en
type
label
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@ast
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@en
prefLabel
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@ast
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@en
P2093
P2860
P1476
Role of the mTOR Pathway in th ...... mical Tissue Microarray Study.
@en
P2093
In Ho Chang
Se Jun Park
Tae Jin Lee
P2860
P304
P356
10.4111/KJU.2011.52.7.466
P577
2011-07-24T00:00:00Z